Renovaro Inc. announces funding approval for LUMINA, a platform detecting minimal residual disease in lung cancer using multi-omics and AI. Renovaro Inc. announced that its subsidiary, RenovaroCube, ...

The National Institutes of Health has awarded nearly a half-million dollars to two University of Dayton researchers exploring strategies for the detection and potential treatment of non-small cell ...

【Backgrounds】 In 2015, the First Affiliated Hospital of Guangzhou Medical University, in collaboration with the Guangdong Hetaoxiang Medical Charity Foundation and the Guangzhou Charity Association, ...

When it comes to health worries, few things feel as serious as hearing about lung cancer. It’s the kind of diagnosis that touches nearly every family at some point, whether through relatives, friends, ...

Scientists have created a new low-cost, fast response sensor to detect lung cancer biomarkers, paving the way for the development of screening devices to spot the disease even before symptoms occur.

New artificial intelligence technology is helping diagnose the U.S.’s most deadly cancer sooner, greatly improving the chances of patients’ survival. The key? Detecting tiny lung nodules when doctors ...